益丰药房
Search documents
A股超3500股上涨,太空光伏、商业航天概念掀涨停潮,巨力索具3连板,中国黄金、白银有色涨停
2 1 Shi Ji Jing Ji Bao Dao· 2026-01-23 04:06
Market Overview - The A-share market experienced a morning surge followed by a pullback, with the three major indices briefly turning negative. As of midday, the Shanghai Composite Index rose by 0.27%, the Shenzhen Component Index increased by 0.24%, while the ChiNext Index fell by 0.17. The total trading volume in the Shanghai and Shenzhen markets reached 1.91 trillion yuan, an increase of 271.8 billion yuan compared to the previous trading day [1][2]. Sector Performance - The AI application concept saw a rise, with Zhejiang Wenlian (600986) achieving two consecutive trading limits. The pharmaceutical commercial sector was active, with People's Tongtai (600829) and Yifeng Pharmacy (603939) hitting the daily limit. Lithium mining stocks strengthened, with Chuaneng Power (000155) rising over 7%, and Tibet Zhufeng (600338) and Guocheng Mining (000688) increasing over 6%. The main contract for lithium carbonate rose over 5%, reaching 178,000 yuan per ton, marking a new high [3]. - The space photovoltaic and commercial aerospace concepts experienced a significant surge, with Jun Da Co., Ltd. (002865) achieving two consecutive trading limits. Other companies like GCL-Poly Energy (002506) and Mingyang Smart Energy (601615) also hit the daily limit. Elon Musk, during a discussion at the World Economic Forum, expressed strong support for space photovoltaics and revealed plans for a solar manufacturing capacity of 100 GW annually within three years [4][5]. Precious Metals - The precious metals sector continued to rise, with gold prices breaking through 1,500 yuan per gram, increasing by over 50 yuan overnight. As of the latest report, spot gold rose by 0.18%, surpassing $4,967, while spot silver increased by 2.61%, exceeding $98 per ounce, both reaching historical highs [6][7]. - Goldman Sachs significantly raised its gold price forecast for December 2026 from $4,900 per ounce to $5,400 per ounce, citing accelerated private investment in gold as a key driver for potential price increases [8].
A股午评:北证50指数涨超3%,商业航天、太空光伏方向全线大涨
2 1 Shi Ji Jing Ji Bao Dao· 2026-01-23 04:04
Market Overview - The A-share market showed mixed performance with the Shanghai Composite Index up by 0.27%, the Shenzhen Component Index up by 0.24%, and the ChiNext Index down by 0.17% as of midday trading [1][2] - The North Star 50 Index surged by 3.36%, with total trading volume in the Shanghai, Shenzhen, and Beijing markets reaching 19,136 billion yuan, an increase of 1,239 billion yuan compared to the previous day [1][2] Sector Performance - Key sectors that saw significant gains include photovoltaic equipment, precious metals, commercial aerospace, pharmaceutical retail, AI applications, horse racing, and battery industries [1][2] - Conversely, sectors that experienced declines include insurance, coal mining and processing, semiconductors, banking, and shale gas [1][2] Notable Stocks - Commercial aerospace and space photovoltaic sectors experienced a collective surge, with stocks like Jieli Suojue achieving three consecutive trading limits, while Zhongchao Holdings, Junda Co., and Western Materials recorded two consecutive limits [1][2] - The retail pharmacy sector performed well due to policy support for mergers and acquisitions, with stocks like Renmin Tongtai and Yifeng Pharmacy hitting trading limits [1][2] - International gold prices approached 5,000 USD, leading to a significant rise in gold stocks, with Baiyin Youse recording four consecutive trading limits [1][2] Market Dynamics - AI applications, battery, and chemical sectors showed notable activity during the trading session [1][2] - Some computing hardware stocks experienced a pullback, with Xinyi Sheng dropping over 6%, and stocks like Tianfu Communication, Zhongji Xuchuang, and Industrial Fulian also declining [1][2] - Several broad-based ETFs saw increased trading volumes, putting pressure on the three major indices [1][2]
A股超3500股上涨,太空光伏、商业航天概念掀涨停潮,巨力索具3连板,中国黄金、白银有色涨停
21世纪经济报道· 2026-01-23 04:01
记者丨张嘉钰 编辑丨江佩佩 1月23日,A股市场早盘冲高回落,三大指数一度集体翻绿。截至午盘,沪指涨0.27%,深成 指涨0.24%,创业板指跌0.17%。沪深两市半日成交额1.91万亿,较上个交易日放量2718亿。 盘面上热点快速轮动,全市场超3500只个股上涨。 | 内地股票 | | | | --- | --- | --- | | 行情 | 资金净流入 | 涨跌分布 | | 上证指数 | 深证成指 | 科创综指 | | 4133.58 | 14360.98 | 1879.53 | | +11.00 +0.27% +33.94 +0.24% +14.18 +0.76% | | | | 万得全A | 创业板指 | 北证50 | | 6870.71 | 3322.96 | 1581.62 | | +43.66 +0.64% -5.69 -0.17% +51.38 +3.36% | | | | 沪深300 | 中证500 | 中证A500 | | 4707.04 | 8515.33 | 5925.01 | | -16.67 -0.35% +127.73 +1.52% +13.24 +0.22% | | | | 中 ...
午评:创业板指冲高回落跌0.17% 商业航天、太空光伏概念持续爆发
Xin Lang Cai Jing· 2026-01-23 03:46
【午评:创业板指冲高回落跌0.17% 商业航天、太空光伏概念持续爆发】智通财经1月23日电,市场早 盘冲高回落,三大指数一度集体翻绿。沪深两市半日成交额1.89万亿,较上个交易日放量194亿。盘面 上热点快速轮动,全市场超3500只个股上涨。从板块来看,光伏概念爆发,太空光伏方向领涨,钧达股 份2连板,协鑫集成、明阳智能、拓日新能等多股涨停。商业航天概念反复活跃,十余只成分股涨停, 金风科技、润贝航科、西部材料涨停。贵金属概念延续强势,白银有色4连板,中国黄金、豫光金铅涨 停。AI应用概念走高,浙文互联4天2板。医药商业概念表现活跃,人民同泰、益丰药房涨停。下跌方 面,算力硬件概念下挫,腾景科技、新易盛均跌超6%。截至收盘,沪指涨0.27%,深成指涨0.24%,创 业板指跌0.17%。 转自:智通财经 ...
A股午评 | 创业板指半日跌0.17% 商业航天引爆太空光伏涨停潮 多只宽基ETF再放量
智通财经网· 2026-01-23 03:43
1月23日,A股早盘窄幅震荡,截至午间收盘,沪指涨0.27%,深成指涨0.24%,创业板指下跌0.17%。 值得注意的是,商业航天带火太空光伏概念,华西证券指出,太空光伏是太空算力数据中心的唯一主能 源与系统级成本拐点,高日照效率与近乎零边际电价让轨道数据中心十年总成本较地面下降一个数量 级。它已成为商业航天和高端应用(如太空算力、数据中心、未来月球基地等)的战略性前沿解决方 案,太空光伏正在迎来其拐点时刻。 此外,值得关注的是,10点后多只宽基ETF集中放量,沪深300ETF华泰柏瑞成交超50亿,南方中证 1000ETF成交超44亿,华夏中证1000ETF成交超35亿,嘉实沪深300ETF、沪深300ETF华夏成交额均超 30亿。 盘面上,商业航天引爆太空光伏涨停潮,钧达股份等超10多股涨停,与此同时,商业航天产业链延续强 势,巨力索具3连板;有色、贵金属概念再度走强,白银有色4连板;医药商业、创新药等医药股概念强 势,益丰药房涨停;传媒等AI应用概端持续反弹,浙文互联4天2板;电网设备概念拉升,三变科技涨 停。下跌方面,燃气、煤炭等周期资源回调,保险、半导体等板块跌幅居前。 展望后市,德邦证券认为,近日市 ...
创业板指冲高回落跌0.17%,商业航天、太空光伏概念持续爆发
Feng Huang Wang Cai Jing· 2026-01-23 03:42
Market Overview - The market experienced a morning surge followed by a pullback, with major indices briefly turning negative. As of the midday close, the Shanghai Composite Index rose by 0.27%, the Shenzhen Component Index increased by 0.24%, while the ChiNext Index fell by 0.17% [1] - The total trading volume in the Shanghai and Shenzhen markets reached 1.89 trillion yuan, an increase of 194 billion yuan compared to the previous trading day [1] Index Performance - Shanghai Composite Index: 4133.58, up 0.27%, with 1411 gainers and 835 losers [2] - Shenzhen Component Index: 14360.98, up 0.24%, with 1901 gainers and 916 losers [2] - ChiNext Index: 3322.96, down 0.17%, with 949 gainers and 419 losers [2] - The North Star 50 Index showed a significant increase of 3.36% [2] Sector Highlights - The photovoltaic sector saw a strong performance, particularly in space photovoltaic stocks, with companies like Junda Co. and Xiexin Integration hitting the daily limit [2] - The commercial aerospace sector was also active, with over ten stocks reaching the daily limit, including Jin Feng Technology and Runbei Aerospace [2] - Precious metals continued to show strength, with silver and non-ferrous metals stocks performing well, including China Gold and Yuguang Gold Lead [2] Other Notable Trends - AI application concepts gained traction, with Zhejiang Wenhu Internet achieving two consecutive limit-ups in four days [3] - The pharmaceutical commercial sector was active, with stocks like Renmin Tongtai and Yifeng Pharmacy hitting the daily limit [3] - Conversely, the computing hardware sector faced declines, with companies like Tengjing Technology and Xinyi Sheng dropping over 6% [3] Market Sentiment - 82.97% of users expressed a bullish outlook on the market [4] - The overall market saw 3507 stocks rising, 199 remaining flat, and 1767 declining, with 79 stocks hitting the daily limit [5] Trading Volume and Activity - The trading volume for the day was reported at 1.89 trillion yuan, reflecting a market heat index of 59, which is an increase of 119.4 billion yuan from the previous day [6] - The limit-up performance rate was recorded at 84%, with a high opening rate of 63% and a profit rate of 60% [7]
九部门联合发文!医药商业股集体上涨,九州通涨超5%
Ge Long Hui· 2026-01-23 02:58
Core Viewpoint - The A-share market for pharmaceutical retail stocks experienced a collective rise, driven by new government measures aimed at enhancing pharmaceutical services and encouraging retail drug sales [1] Group 1: Market Performance - Pharmaceutical retail stocks such as Renmin Tongtai and Yifeng Pharmacy hit the daily limit up, while Luyuan Pharmaceutical rose over 7%, Daclin increased over 6%, and Jiuzhoutong gained over 5% [1] - Other notable performers included Zhongyao Holdings, Yaoyigou, Haiwang Biological, Hefuchina, and Shuyupingmin, all rising over 4% [1] Group 2: Government Measures - The Ministry of Commerce and nine other departments issued a document proposing improvements in pharmaceutical services, enhancing pharmacy service capabilities, and promoting prescription circulation to improve the purchasing experience [1] - Measures include optimizing outpatient service coordination for designated retail pharmacies and encouraging retail drug companies to participate in centralized drug procurement [1] - The government is promoting horizontal mergers and acquisitions among retail drug companies and encouraging the sale of innovative drugs and reference preparations through retail channels [1] - There is an emphasis on encouraging e-pharmacy platforms to open data interfaces and strengthen the monitoring of price linkages between online and offline drug retail prices and provincial procurement platform prices [1]
贵金属概念股高开,黄金白银大涨!
Zheng Quan Shi Bao Wang· 2026-01-23 02:58
(原标题:黄金白银大涨!) 1月23日,A股三大指数集体高开。盘面上,黄金概念、化纤、有色、商业连锁等板块涨幅居前;半导体、家居用品、旅游等板块跌幅居前。 港股方面,恒生指数和恒生科技指数均飘红。微创医疗涨超9%,长飞光纤光缆涨超8%,老铺黄金、泡泡玛特等涨逾6%,阿里巴巴涨超3%,小米 集团涨超2%。 (原标题:贵金属概念股高开,黄金白银大涨!) 贵金属概念股高开 湖南白银涨超8%,四川黄金、中金黄金、山金国际、晓程科技等跟涨。 23日早盘,现货黄金持续拉涨,盘中一度触及4960美元/盎司,截至发稿,小幅回落。现货白银突破98美元/盎司,国内沪银期货主力合约涨幅扩 大至7.79%,报24802元/千克。 当地时间周二,波兰央行表示,该行已批准一项购买多达150吨黄金的计划,这将使该国的黄金储备增加到700吨。 商业航天概念延续强势 巨力索具3连板,中超控股2连板,德恩精工、睿创微纳涨幅居前,飞沃科技、信科移动、金风科技、烽火通信冲高。 券商研报指出,商业航天产业方兴未艾,正迈入需求侧与供给侧双向发力的黄金时代。民营火箭公司发展迅速,产业链处于国家航天向商业航天 的转变阶段。另外,当前低轨卫星主要集中在空间段 ...
A股异动丨九部门联合发文!医药商业股集体上涨,九州通涨超5%
Ge Long Hui A P P· 2026-01-23 02:53
Group 1 - The core viewpoint of the article highlights a collective rise in A-share pharmaceutical commercial stocks, driven by government initiatives to enhance pharmaceutical services and retail drug sales [1] - The Ministry of Commerce and nine other departments issued a document proposing measures to improve pharmaceutical services, enhance pharmacy service capabilities, and promote prescription circulation to improve the purchasing experience [1] - The document encourages pharmaceutical retail companies to engage in horizontal mergers and acquisitions, and to innovate in drug sales channels, including the sale of innovative drugs and reference preparations through retail pharmacies [1] Group 2 - Notable stock performances include: - Renmin Tongtai (人民同泰) with a rise of 10.04% and a total market value of 72.43 billion [2] - Yifeng Pharmacy (益丰药房) increasing by 10.02% with a market cap of 301 billion [2] - Luyuan Pharmaceutical (鹭燕医药) up by 7.76% with a market value of 70.13 billion [2] - Dacelin (大参林) rising by 6.63% with a market cap of 242 billion [2] - Jiuzhoutong (九州通) increasing by 5.27% with a market value of 282 billion [2] - Other companies showing significant gains include Zhongyao Holdings (重药控股) up by 4.89%, Yaoyigou (药易购) up by 4.42%, and Haiwang Biological (海王生物) up by 4.41% [2]
药店零售股拉升,人民同泰、益丰药房涨停,药易购等大涨
Zheng Quan Shi Bao Wang· 2026-01-23 02:29
Core Viewpoint - The retail pharmacy sector experienced a significant rise in stock prices following the release of a government policy aimed at promoting high-quality development in the pharmaceutical retail industry [1] Group 1: Policy Impact - On January 22, the Ministry of Commerce and nine other departments issued guidelines to encourage horizontal mergers and acquisitions in the pharmaceutical retail sector [1] - The policy aims to optimize the business environment for retail pharmacies, including streamlining the application process for drug operating licenses for consolidated chain or standalone pharmacies [1] - It promotes the integration of wholesale and retail operations to enhance supply chain efficiency and reduce operational costs through shared logistics resources and collaborative quality management systems [1] Group 2: Market Outlook - According to Guojin Securities, leading compliant pharmacy chains are expected to benefit first from the ongoing regulatory push for industry standardization [1] - Companies that have proactively adjusted their store operations are projected to see a marginal recovery in revenue by the third quarter of 2025 [1] - Some leading companies are beginning to explore non-pharmaceutical product offerings, which could become a significant source of profit if they exceed expectations in performance [1]